RecruitingPhase 2NCT07361120

Plan A Occlusion and Reversal System Feasibility Study

Prospective, Multicenter, Single-arm, Open Label, Interventional Clinical Trial Investigating the Safety and Effectiveness of the Plan A Male Contraceptive System.

Sponsor

Next Life Sciences

Enrollment

40 participants

Start Date

Jan 15, 2026

Study Type

INTERVENTIONAL

Conditions

Fertility Fertility, Male Healthy Male Adults

Summary

Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of sperm through the vas deferens.

Eligibility

Sex: MALEMin Age: 25 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Occlusion System for people with fertility, fertility, male, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 25 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.